Literature DB >> 28356333

Patients' reports of adverse events: a data linkage study of Australian adults aged 45 years and over.

Merrilyn Margaret Walton1, Reema Harrison1, Patrick Kelly1, Jennifer Smith-Merry2, Elizabeth Manias3, Christine Jorm4, Rick Iedema5.   

Abstract

BACKGROUND: Understanding a patient's hospital experience is fundamental to improving health services and policy, yet, little is known about their experiences of adverse events (AEs). This study redresses this deficit by investigating the experiences of patients in New South Wales hospitals who suffered an AE.
METHODS: Data linkage was used to identify a random sample of 20 000 participants in the 45 and Up Cohort Study, out of 267 153 adults aged 45 years and over, who had been hospitalised in the prior 6 months. A cross-sectional survey was administered to these patients to capture their experiences, including whether they had an AE and received honest communication about it.
RESULTS: Of the 18 993 eligible participants, 7661 completed surveys were received (40% response rate) and 474 (7%) reported having an AE. Most AEs related to clinical processes and procedures (33%), or medications and intravenous fluids (21%). Country of birth and admission through emergency were significant predictors of the occurrence of an event. An earlier admission in the prior 6 months or a transfer to another healthcare facility was also associated with more AEs. Of those who suffered an AE, 58% reported serious or moderate effects.
CONCLUSIONS: Given the exclusions in our sample population (under 45 years), the AE rate reported by patients of 7% is similar to the approximately 10% rate reported in the general population by retrospective medical record reviews. AE data that include patient experience may provide contextual information currently missing. Capturing and using patient experience data more effectively is critical; there may be opportunities for applying co-design methodology to improve the management of AEs and be more responsive to patients' concerns. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Adverse events, epidemiology and detection; Patient safety; Patient satisfaction; Patient-centred care

Mesh:

Year:  2017        PMID: 28356333     DOI: 10.1136/bmjqs-2016-006339

Source DB:  PubMed          Journal:  BMJ Qual Saf        ISSN: 2044-5415            Impact factor:   7.035


  6 in total

1.  Health Care Provider Factors Associated with Patient-Reported Adverse Events and Harm.

Authors:  Traber D Giardina; Kathryn E Royse; Arushi Khanna; Helen Haskell; Julia Hallisy; Frederick Southwick; Hardeep Singh
Journal:  Jt Comm J Qual Patient Saf       Date:  2020-02-21

Review 2.  Learning from complaints in healthcare: a realist review of academic literature, policy evidence and front-line insights.

Authors:  Jackie van Dael; Tom W Reader; Alex Gillespie; Ana Luisa Neves; Ara Darzi; Erik K Mayer
Journal:  BMJ Qual Saf       Date:  2020-02-04       Impact factor: 7.035

3.  Open disclosure of adverse events: exploring the implications of service and policy structures on practice.

Authors:  Reema Harrison; Merrilyn Walton; Jennifer Smith-Merry; Elizabeth Manias; Rick Iedema
Journal:  Risk Manag Healthc Policy       Date:  2019-01-23

4.  Patient Voices in Hospital Safety during the COVID-19 Pandemic.

Authors:  Patricia S Groves; Jacinda L Bunch; Kirsten M Hanrahan; Kathryn A Sabadosa; Brittaney Sharp; Janet K Williams
Journal:  Clin Nurs Res       Date:  2022-10-17       Impact factor: 1.724

5.  A profile of the Centre for Health Record Linkage.

Authors:  K Irvine; R Hall; L Taylor
Journal:  Int J Popul Data Sci       Date:  2019-11-29

6.  Beyond translation: Engaging with culturally and linguistically diverse consumers.

Authors:  Reema Harrison; Merrilyn Walton; Upma Chitkara; Elizabeth Manias; Ashfaq Chauhan; Monika Latanik; Desiree Leone
Journal:  Health Expect       Date:  2019-10-18       Impact factor: 3.377

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.